Cargando…
CD1a expression by Barrett's metaplasia of gastric type may help to predict its evolution towards cancer
As emerging in the recent literature, CD1a has been regarded as a molecule whose expression may reflect tumour evolution. The aim of the present work was to investigate the expression of CD1a in a series of Barrett's metaplasia (BM), gastric type (GTBM), with and without follow-up, in order to...
Autores principales: | Cappello, F, Rappa, F, Anzalone, R, La Rocca, G, Zummo, G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361916/ https://www.ncbi.nlm.nih.gov/pubmed/15756258 http://dx.doi.org/10.1038/sj.bjc.6602415 |
Ejemplares similares
-
Barrett’s Esophagus and Intestinal Metaplasia
por: Zhang, Lu, et al.
Publicado: (2021) -
CD80 expression promotes immune surveillance in Barrett’s metaplasia
por: Scarpa, Melania, et al.
Publicado: (2019) -
Evolving management of metaplasia and dysplasia in Barrett's epithelium
por: Evans, Richard P T, et al.
Publicado: (2016) -
Recurrent intestinal metaplasia at the gastroesophageal junction following endoscopic eradication of dysplastic Barrett’s esophagus may not be benign
por: Cameron, Georgina R., et al.
Publicado: (2016) -
Interleukin-17 Expression in the Barrett's Metaplasia-Dysplasia-Adenocarcinoma Sequence
por: Bannister, J. R., et al.
Publicado: (2012)